Agios Reports Business Highlights and Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Agios Pharma (AGIO) Misses Q2 EPS by 17c
August 1, 2019 7:45 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.87), $0.17 worse than the analyst estimate of ($1.70). Revenue for the quarter came in at $26.2 million versus the consensus estimate of $27.05 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More


